sCD44 overexpression increases intraocular pressure and aqueous outflow resistance

Molecular Vision

Volumn 19, Issue , 2013, Pages 2151-2164

  Giovingo, Michael ^a   Nolan, Michael ^a   McCarty, Ryan ^a   Pang, Iok Hou ^b   Clark, Abbot F ^b   Beverley, Rachel M ^a   Schwartz, Steven ^a   Stamer, W Daniel ^c   Walker, Loyal ^a   Grybauskas, Algis ^a   Skuran, Kevin ^a   Kuprys, Paulius V ^a   Yue, Beatrice Y J T ^a   Knepper, Paul A ^a,d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GAMMA SECRETASE INHIBITOR; HERMES ANTIGEN; LIPOCORTIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR OUTFLOW; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MOUSE; GENE; GENE CONSTRUCT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRAOCULAR HYPERTENSION; LIPID RAFT; MOUSE; NONHUMAN; OPEN ANGLE GLAUCOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SCD44 GENE; TRABECULAR MESHWORK; UPREGULATION; WESTERN BLOTTING;

ACTINS; ADENOVIRIDAE; ADULT; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANTERIOR EYE SEGMENT; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD44; AQUEOUS HUMOR; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HUMANS; IMMUNOBLOTTING; INTRAOCULAR PRESSURE; JURKAT CELLS; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED BALB C; MIDDLE AGED; PERFUSION; SOLUBILITY; SUS SCROFA; TRABECULAR MESHWORK; TRANSDUCTION, GENETIC; YOUNG ADULT;

EID: 84887195950     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet 2004; 363:1711-20.[PMID: 15158634]
2. Knepper PA, Mayanil CS, Goossens W, Wertz RD, Holgren C, Ritch R, Allingham RR. Aqueous humor in primary open-angle glaucoma contains an increased level of CD44S. Invest Ophthalmol Vis Sci 2002; 43:133-9.[PMID: 11773 0 23]
3. Nolan MJ, Giovingo MC, Miller AM, Wertz RD, Ritch R, Liebmann JM, Allingham RR, Herndon LW, Wax MB, Smolyak R, Hasan F, Barnett EM, Samples JR, Knepper PA. Aqueous humor sCD44 concentration and visual field loss in primary open-angle glaucoma. J Glaucoma 2007; 16:419-29.[PMID: 1770 0 283]
4. Choi J, Miller AM, Nolan MJ, Yue BY, Thotz ST, Clark AF, Agarwal N, Knepper PA. sCD44 is cytotoxic to trabecular meshwork and retinal ganglion cells in vitro. Invest Ophthalmol Vis Sci 2005; 46:214-22.[PMID: 15623776]
5. Zöller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 2011; 11: 25 4-67.[PMID: 21390059]
6. Kincade PW, Zheng Z, Katoh S, Hanson L. The importance of cellular environment to function of the CD44 matrix receptor. Curr Opin Cell Biol 1997; 9:635-42.[PMID: 9330866]
7. Cichy J, Pure E. The liberation of CD44. J Cell Biol 2003; 161:839-843.[PMID: 12796 473]
8. Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res 1997; 71:241-319.[PMID: 9111868]
9. Knepper PA, Samples JR, Yue BYJT. Biomarkers of primary open-angle glaucoma. Expert Rev Ophthalmol 2010; 5:731-42.
10. Naor D, Nedvetzki S, Walmsley M, Yayon A, Turley EA, Golan I, Caspi D, Sebban LE, Zick Y, Garin T, Karussis D, Assayag-Asherie N, Raz I, Weiss L, Slavin S, Golan I. CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout mice. Ann NY Acad Sci 2007; 1110:233-47.[PMID: 17911438]
11. Vachon E, Martin R, Kwok V, Cherepanov V, Chow CW, Doerschuk CM, Plumb J, Grinstein S, Downey GP. CD44-mediated phagocytosis induces inside-out activation of complement receptor-3 in murine macrophages. Blood 2007; 110:4492-502.[PMID: 1782739 2]
12. Ghatak S, Misra S, Toole BP. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 2002; 277:38013-20.[PMID: 12145277]
13. Hegde VL, Singh NP, Nagarkatti PS, Nagarkatti M. CD44 mobilization in allogeneic dendritic cell-T cell immuno-logical synapse plays a key role in T cell activation. J Leukoc Biol 2008; 84:134-42.[PMID: 18388297]
14. Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol 2008; 18:260-7.[PMID: 18467123]
15. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 2001; 153:893-904.[PMID: 113810 77]
16. Seiki M. The cell surface: the stage for matrix metallopro-teinase regulation of migration. Curr Opin Cell Biol 2002; 14: 624-32.[PMID: 12231359]
17. Lammich S, Okochi M, Takeda M, Kaether C, Capell A, Zimmer AK, Edbauer D, Walter J, Steiner H, Haass C. Prese-nilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Aβ-like peptide. J Biol Chem 2002; 277:44754-9.[PMID: 12223485]
18. Shepard AR, Millar JC, Pang IH, Jacobson N, Wang WH, Clark AF. Adenoviral gene transfer of active human transforming growth factor-β2 elevates intraocular pressure and reduces outflow facility in rodent eyes. Invest Ophthalmol Vis Sci 2010; 51:2067-76.[PMID: 19959644]
19. Wang WH, Millar JC, Pang IH, Wax MB, Clark AF. Noninvasive measurement of rodent intraocular pressure with a rebound tonometer. Invest Ophthalmol Vis Sci 2005; 46:4617-21.[PMID: 16303957]
20. Nolan MJ, Koga T, Walker L, McCarty R, Grybauskas A, Giovingo MC, Skuran K, Kuprys PV, Knepper PA. sCD44 internalization in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2013; 54:592-601.[PMID: 23287794]
21. Bradley JMB, Vranka J, Colvis CM, Conger DM, Alexander JP, Fisk AS, Samples JR, Acott TS. Effect of matrix metal-loproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci 1998; 39:2649-58.[PMID: 9856774]
22. Keller KE, Bradley JM, Kelley MJ, Acott TS. Effects of modifiers of glycosaminoglycan biosynthesis on outflow facility in perfusion culture. Invest Ophthalmol Vis Sci 2008; 49:2495-505.[PMID: 18515587]
23. Stamer WD, Seftor RE, Williams SK, Samaha HA, Synder RW. Isolation and culture of trabecular meshwork cells by extracellular matrix digestion. Curr Eye Res 1995; 14:611-7.[PMID: 7587308]
24. Stamenkovic I, Yu Q. Shedding light on proteolytic cleavage of CD44: the responsible sheddase and functional significance of shedding. J Invest Dermatol 2009; 129:1321-4.[PMID: 19434087]
25. Ildefonso CJ, Bond WS, Al-Tawashi AR, Hurwitz MY, Hurwitz RL. The liberation of CD44 intracellular domain modulates adenoviral vector transgene expression. J Biol Chem 2012; 287: 32 697-707.[PMID: 22865879]
26. Robertson J V, Golesic E, Gauldie J, West-Mays JA. Ocular gene transfer of active TGF-β induces changes in anterior segment morphology and elevated IOP in rats. Invest Ophthalmol Vis Sci 2010; 51:308-18.[PMID: 19696167]
27. Oh DJ, Kang MH, Choi KR, Sage EH, Rhee DJ. Adenoviral gene transfer of SPARC to human trabecular meshwork elevates intraocular pressure. Paper presented at: The ARVO Annual Meeting; May 4, 2011; Fort Lauderdale, FL.
28. Wang WH, McNatt LG, Pang IH, Millar JC, Hellberg PE, Hellberg MH, Steely HT, Rubin JS, Fingert JH, Sheffield VC, Stone EM, Clark AF. Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressure. J Clin Invest 2008; 118:1056-64.[PMID: 18274 6 69]
29. Wang WH, McNatt LG, Pang IH, Hellberg PE, Fingert JH, McCartney MD, Clark AF. Increased expression of serum amyloid A in glaucoma and its effect on intraocular pressure. Invest Ophthalmol Vis Sci 2008; 49:1916-23.[PMID: 18223246]
30. Yokoi K, Zhang HS, Kachi S, Balaggan KS, Yu Q, Guschin D, Kunis M, Surosky R, Africa LM, Bainbridge JW, Spratt SK, Gregory PD, Ali RR, Campochiaro PA. Gene transfer of an engineered zinc finger protein enhances the anti-angiogenic defense system. Mol Ther 2007; 15:1917-23.[PMID: 17700545]
31. Gabelt BT, Hu Y, Vittitow JL, Rasmussen CR, Grosheva I, Bershadsky AD, Geiger B, Borrás T, Kaufman PL. Calde-smon transgene expression disrupts focal adhesions in HTM cells and increases outflow facility in organ-cultured human and monkey anterior segments. Exp Eye Res 2006; 82:935-44.[PMID: 16442523]
32. Borrás T, Bryant PA, Chisolm SS. First look at the effect of overexpression of TIGR/MYOC on the transcriptome of the human trabecular meshwork. Exp Eye Res 2006; 82:1002-10.[PMID: 16476427]
33. Knudson CB, Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J 1993; 7:1233-41.[PMID: 7691670]
34. Rajasagi M, von Au A, Singh R, Hartmann N, Zöller M, Marhaba R. Anti-CD44 induces apoptosis in T lymphoma via mitochondrial depolarization. J Cell Mol Med 2010; 14:1453-67.[PMID: 19765170]
35. Howes MT, Kirkham M, Riches J, Cortese K, Walser PJ, Simpson F, Hill MM, Jones A, Lundmark R, Lindsay MR, Hernandez-Deviez DJ, Hadzic G, McCluskey A, Bashir R, Liu L, Pilch P, McMahon H, Robinson PJ, Hancock JF, Mayor S, Parton RG. Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells. J Cell Biol 2010; 190:675-91.[PMID: 20713605]
36. Clark AF, Brotchie D, Read AT, Hellberg P, English-Wright S, Pang IH, Ethier CR, Grierson I. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil Cytoskeleton 2005; 60:83-95.[PMID: 155932 81]
37. O'Reilly S, Pollock N, Currie L, Paraoan L, Clark AF, Grierson I. Inducers of cross-linked actin networks in trabecular mesh-work cells. Invest Ophthalmol Vis Sci 2011; 52:7316-24.[PMID: 21849423]
38. Gerke V, Weber K. Identity of p36K phosphorylated upon Rous sarcoma virus transformation with a protein purified from brush borders; calcium-dependent binding to non-erythroid spectrin and F-actin. EMBO J 1984; 3:227-33.[PMID: 6323166]
39. Filipenko NR, Waisman DM. The C-terminus of annexin II mediates binding to Factin. J Biol Chem 2001; 276:5310-5.[PMID: 110 67857]
40. Hayes MJ, Shao D, Bailly M, Moss SE. Regulation of actin dynamics by annexin 2. EMBO J 2006; 25:1816-26.[PMID: 16601677]
41. Hayes MJ, Merrifield CJ, Shao D, Ayala-Sanmartin J, Schorey CD, Levine TP, Proust J, Curran J, Bailly M, Moss SE. Annexin 2 binding to phosphatidylinositol 4,5-bisphosphate on endocytic vesicles is regulated by the stress response pathway. J Biol Chem 2004; 279:14157-64.[PMID: 14734570]
42. Scott PA, Lu Z, Liu Y, Gong H. Relationships between increased aqueous outflow facility during washout with the changes in hydrodynamic pattern and morphology in bovine aqueous outflow pathways. Exp Eye Res 2009; 89:942-9.[PMID: 19679123]
43. Nandi A, Estess P, Siegelman MH. Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44. J Biol Chem 2000; 275:14939-48.[PMID: 10809739]
44. Lennon FE, Singleton PA. Hyaluronan regulation of vascular integrity. Am J Cardiovasc Dis. 2011; 1:200-13.[PMID: 22254199]
45. Last JA, Pan T, Ding Y, Reilly CM, Keller K, Acott TS, Fautsch M P, Murphy CJ, Russell P. Elastic modulus determination of normal and glaucomatous human trabecular meshwork. Invest Ophthalmol Vis Sci 2011; 52:2147-52.[PMID: 212 2 0561]
46. Legg JW, Lewis CA, Parson M, Ng T, Isacke CM. A novel PKC-regulated mechanism controls CD44 ezrin association and directional cell motility. Nat Cell Biol 2002; 4:399-407.[PMID: 12032545]
47. Tzircotis G, Thorne RF, Isacke CM. Directional sensing of a phorbol ester gradient requires CD44 and is regulated by CD44 phosphorylation. Oncogene 2006; 25:7401-10.[PMID: 167859 95]
48. Isacke CM, Yarwood H. The hyaluronan receptor, CD44. Int J Biochem Cell Biol 2002; 34:718-21.[PMID: 11950588]